ZIOPHARM Oncology, Inc. is a company in the U.S. stock market and it is a holding in 38 U.S.-traded ETFs. ZIOP has around 18.3M shares in the U.S. ETF market. The largest ETF holder of ZIOP is the SPDR S&P Biotech ETF (XBI), with approximately 5.08M shares. Investors may also find of interest that the ETF with the largest allocation to ZIOP stock is Global X Genomics & Biotechnology ETF (GNOM), with a portfolio weight of 0.79%. On average, U.S. ETFs allocate 0.09% of ZIOP to their portfolios.
Additionally, ZIOP is a favorite stock for Vanilla and Equal ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ZIOP as a holding is the iShares Genomics Immunology and Healthcare ETF (IDNA), with a return of 51.86%.